Enzyme Immunoassay Market to Grow at 7.2% CAGR, Reaching $28.37 Billion by 2029

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

Enzyme Immunoassay Market Outlook: How is the Market Expected to Grow by 2025?
In recent times, the enzyme immunoassay market has experienced significant expansion. The market size is anticipated to escalate from $20.01 billion in 2024 to $21.50 billion in 2025, marking a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this historic growth include an increase in infectious diseases, the expansion of blood screening initiatives, enhanced laboratory facilities, a surge in usage for food safety examinations, and an increased requirement for veterinary diagnostics.

Enzyme Immunoassay Market Forecast: What Size Will It Reach By 2029?
The market size for enzyme immunoassay is anticipated to witness robust growth in the coming years, projected to reach $28.37 billion by 2029 with a compound annual growth rate (CAGR) of 7.2%. This growth in the predicticted period can be linked to government and NGO-led initiatives for controlling diseases, the development of autoimmune disease detection methods, increased preference for point-of-care testing, increasing need for companion diagnostics in the field of oncology, and a growing older population. Significant trends expected in this period include advances in technologies for microplate readers and reagents, the introduction of cutting-edge diagnostic technologies, the production of environmentally-friendly reagents, the incorporation of Artificial Intelligence and automation in immunoassays, and strategic collaborations and partnerships.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Key Market Drivers Will Shape Enzyme Immunoassay Industry Trends in 2025-2029?
The escalating prevalence of infectious diseases is projected to drive the expansion of the enzyme immunoassay market. These diseases, caused by harmful microorganisms like bacteria, viruses, fungi, or parasites, are spreadable from one individual to another. With antimicrobial resistance intensifying the challenges in treating common infections, the burden of infectious diseases is subsequently increasing, resulting in extended illnesses, elevated healthcare costs and increased fatalities. Enzyme immunoassays play a crucial role in detecting infectious diseases as they facilitate the accurate and intricate identification of antigens or antibodies in patient samples. This enables early detection, effective surveillance and prompt treatment of infections such as HIV, hepatitis, and influenza. As an example, the Minnesota Department of Health, a US governmental institution, reported in April 2025 that the percentage of HIV cases among males aged 35 to 39 had grown from 10% in 2023 to 17% in 2024. This signifies a significant rise in this age group's ratio of overall cases. Thus, the accelerating prevalence of infectious diseases is contributing to the growth of the enzyme immunoassay market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

What Are the High-Growth Segments in the Enzyme Immunoassay Market?
The enzyme immunoassay market covered in this report is segmented -

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services
2) By Specimen: Blood, Saliva, Urine, Other Specimens
3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:
1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers
2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators
3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

Which Global Trends Are Driving Enzyme Immunoassay Market Expansion?
Renowned organizations in the enzyme immunoassay market are concentrating on launching creative enzyme immunoassay (EIA) options such as fully automated enzyme immunoassays for better diagnostic precision, reduced manual blunders, and improved workflow efficiency in clinical labs. Fully automated enzyme immunoassays are diagnostic apparatus that execute the whole testing procedure autonomously, which accelerates the process and improves the accuracy and reliability of laboratory results. For example, in July 2024, Japan's in vitro diagnostics (IVD) company, Fujirebio Holdings Inc., introduced the fully automated Lumipulse G GFAP assay solely for research purposes, thereby growing its neuro-biomarker portfolio. This research use only chemiluminescent enzyme immunoassay gauges glial fibrillary acidic protein (GFAP) in human plasma and serum by using the LUMIPULSE G platform and provides results in a mere 35 minutes. It functions as an astrocytic biomarker implicated in conditions like multiple sclerosis, Alzheimer's and Parkinson's illnesses, stroke, and traumatic brain injury. This assay enhances Fujirebio's growing neuro menu, which already comprises NfL, pTau217, and sTREM2, offering comprehensive neurodegenerative disease profiling on a single automated system.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Who Are the Fastest-Growing Companies in the Enzyme Immunoassay Industry?
Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

What Is the Regional Outlook for the Enzyme Immunoassay Market by 2029?
North America was the largest region in the enzyme immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Speak With Our Expert: Saumya Sahay: Americas +1 310-496-7795: Asia +44 7882 955267 & +91 8897263534: Europe +44 7882 955267: Email: saumyas@tbrc.info: The Business Research Company - www.thebusinessresearchcompany.com: Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.